Related Experiment Video
Updated: Jul 8, 2025

07:36
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
11.4K
Amniotic fluid embolism: a reappraisal.
Bruce K Young1,2, Pascalle Florine Magdelijns3, Judith L Chervenak4
1Department of Obstetrics and Gynecology, New York University Grossman School of Medicine, New York City, USA.
Journal of Perinatal Medicine
|December 12, 2023
Summary
New criteria improve amniotic fluid embolism (AFE) diagnosis, identifying more cases with fewer false positives. This study also highlights potential risk factors like advanced maternal age and cesarean delivery, proposing a novel pathophysiology theory.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Critical Care Medicine
Background:
- Amniotic fluid embolism (AFE) is a rare but catastrophic obstetric emergency with high maternal mortality.
- Existing diagnostic criteria for AFE may not capture all true cases, potentially delaying critical interventions.
- Understanding AFE pathophysiology and associated risk factors is crucial for improving patient outcomes.
Approach:
- This retrospective case review analyzed 29 cases of amniotic fluid embolism (AFE), including 8 from institutional experience and 21 from published literature.
- Cases were evaluated using both established (Clark et al.) and newly proposed diagnostic criteria for AFE.
- Clinical and demographic data were collected to identify potential risk factors and analyze correlations.
Key Points:
- The proposed diagnostic criteria identified all 29 AFE cases, unlike existing criteria which identified none.
- Identified risk factors include advanced maternal age (≥32 years), in-vitro fertilization, placenta previa, and cesarean delivery (particularly elective).
- The incidence of AFE was 2.9 per 100,000 births, with a maternal mortality rate of 17.2% in this series.
Conclusions:
- The developed criteria offer improved sensitivity for AFE diagnosis with a low false-positive rate.
- Findings support previously reported associations and suggest a potential link between cesarean birth and AFE risk.
- A novel hypothesis for AFE pathophysiology is proposed, warranting further investigation.
Related Concept Videos
Pleural Effusion I: Introduction
1.1K
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
1.1K
Pleural Effusion II: Symptoms and Management
181
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
181

